Advertisement

Topics

Latest "Proteome Sciences Plc." News Stories

06:51 EST 23rd January 2019 | BioPortfolio

Here are the most relevant search results for "Proteome Sciences Plc." found in our extensive news archives from over 250 global news sources.

More Information about Proteome Sciences Plc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Proteome Sciences Plc. for you to read. Along with our medical data and news we also list Proteome Sciences Plc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Proteome Sciences Plc. Companies for you to search.

Showing "Proteome Sciences" News Articles 1–25 of 3,800+

Wednesday 23rd January 2019

STEMCELL Technologies Launches mTeSR™ Plus, a Next-Generation Culture System for Human ES and iPS Cell Maintenance

STEMCELL Technologies has released mTeSR™ Plus, an enhanced version of mTeSR™1, the most widely published


ExxonMobil and Renewable Energy Group Partner with Clariant to Advance Cellulosic Biofuel Research

Partnership to expand on joint ExxonMobil and REG research into cellulosic biodiesel Clariant’s sunliquid® technology to facilitate creation of compatible cellulosic sugars Objective is to combine technologies into a single, integrated biodiesel production process

Tuesday 22nd January 2019

AHF Criticizes White House Appointment of Joe Grogan, Former Gilead Lobbyist, as Domestic Policy Advisor

AIDS group laments fact that Washington’s revolving door continues: private industry executives cycle into key government positions, then back to private sector—often to the detriment of the public good The White House announced that U.S. President Donald Trump has appointed Joe Grogan to serve as Domestic Policy Adviser on his White House staff (Po


Gilead Sciences to Release Fourth Quarter and Full Year 2018 Financial Results on Monday, February 4, 2019

-- Conference Call and Webcast to Follow -- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2018 financial results will be released on Monday, February 4, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the f...

Vertex to Announce Full-Year and Fourth-Quarter 2018 Financial Results on February 5

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its full year and fourth quarter 2018 financial results on Tuesday, February 5, 2019 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). ...

How to Manage CRO RFPs to Cut Your Clinical Outsourcing Planning Time in Half, New Webinar Hosted by Xtalks

Clinical outsourcing can be difficult to manage – but it doesn’t have to be. Learn how to make updates to request for proposals (RFPs) quickly, compare proposals to each other, leverage benchmark pricing for vendor negotiations and more in this free webinar. TORONTO (PRWEB) January 22, 2019 Outsourcing trials to contract research organizations (CRO) can be difficult since each trial has its o...

2019 ISPE Europe Annual Conference Keynote Speakers Announced

Keynote addresses will showcase global pharmaceutical industry leaders offering compelling and enlightening presentations on industry-critical technical developments. BETHESDA, Md. (PRWEB) January 22, 2019 The International Society for Pharmaceutical Engineering (ISPE) announced its keynote speakers for their 2019 Europe Annual Conference. Taking place in Dublin, Ireland, 1–4 April 2019, keynot...

Sheppard Mullin Continues Washington, D.C. Expansion

Firm Adds Life Sciences/FDA Partner Allison Fulton Sheppard, Mullin, Richter & Hampton LLP is pleased to announce that Allison Fulton has joined its Washington, D.C. office as a partner in the Life Sciences and FDA team. Fulton joins Sheppard Mullin from Sidley Austin LLP. "2018 was another busy year for Sheppard Mullin’s Washington...

Georgia Bio to Celebrate 30 Years at Annual Awards Dinner

GRA’s Russell Allen and Inventor Richard Hillstead to Receive Top Honors Georgia Bio, the state’s life science trade association, will celebrate its 30th Anniversary Gala & Annual Golden Helix Awards on Friday, February 8 at the Hyatt at Villa Christina in Atlanta. Georgia Bio is pleased to announce the winners of the 2019 Golden Helix Awards. ...

LabCorp Named to FORTUNE Magazine's 2019 List of ‘World’s Most Admired Companies,’ Making the Annual List for the Second Consecutive Year

LabCorp® (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE magazine's 2019 List of World’s Most Admired Companies, making the annual list for the second consecutive year. The annual survey, conducted by FORTUNE and Korn Ferry, a global organizational consulting firm, is give...

Particle Sciences launches new API screening programme

Contract development and manufacturing organisation (CDMO) Particle Sciences has launched a new active pharmaceutical ingredient (API) screening programme in order to strengthen its nanomilling offering.

Waters Expands Accessibility to High Resolution MS Data with the First SmartMS-Enabled LC-MS Biopharma System

As the Number of Analytical Monitoring Tests for Biopharmaceuticals Skyrockets, Waters Builds Intelligence into a Fit-for-Purpose System Waters Corporation (NYSE:WAT) today introduced the BioAccord™ System, a purposefully designed liquid chromatography-mass spectrometry (LC-MS) solution that will expand access to high-resolution time-of-flight mass ...

IQVIA Named to FORTUNE’s 2019 List of “World’s Most Admired Companies”

IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has once again been named to FORTUNE magazine’s “World’s Most Admired Companies” list. IQVIA received the distinction in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks in quality of management, effectiveness in conducting business globally, wise use of corporate assets, and value ...

Immunochina Raises $20.4 Million USD in Series C Financing

Beijing-based Immunochina Pharmaceuticals today announced the closing of its $140 million RMB Series C financing (approximately $20.4 million in US Dollars). This financing will enable the company to expand its GMP-grade manufacturing capabilities while continuing clinical trials for its lead IM19 product targeting B-Cell Acute Lymphoblastic Leukemia (B-AL...

Three things that pharma executives must do to keep pace with the healthcare evolution

While the life sciences industry has been evolving rapidly, its commercial sales model has largely stayed the same. Why do pharma companies need to now rethink the role of the sales rep?

Wren Therapeutics Completes £18 Million Series A Financing

Investment will enable company to accelerate pipeline for protein misfolding diseases, of which there are more than 50 in total Broad pipeline of small molecule and antibody therapeutics, as well as diagnostics, spanning neurology, ophthalmology and metabolic diseases Proprietary and novel approach based on physical prin...

EMMAC Life Sciences PLC: Acquisition of a Majority Interest in Medalchemy, a GMP Certified Laboratory, in Alicante Spain

EMMAC, the European independent medical cannabis company, is pleased to announce the acquisition of a majority interest in Medalchemy, a fully-licensed GMP certified laboratory in Alicante, Spain. Medalchemy, a technology-based manufacturing company located on the premises of the University of Alicante, has more than a decade of experience in the ...

Monday 21st January 2019

Opinion: Bills that support the idea of building more public-private partnerships in the health and life sciences sectors, like the Warren-Schakowsky bill, are worth exploring. https://buff.ly/2RECoEN 

Opinion: Bills that support the idea of building more public-private partnerships in the health and life sciences sectors, like the Warren-Schakowsky bill, are worth exploring. https://buff.ly/2RECoEN 

Study increases understanding of how the brain distinguishes between self-touch and touch by others

Our brains seem to reduce sensory perception from an area of our skin when we touch it ourselves, according to a new study from Linköping University published in the journal Proceedings of the National Academy of Sciences, PNAS.

Medical Science Liaison Jobs: The Best-Kept Secret in the Life Sciences Industry

Based on research done by the MSL Society, the MSL role could grow by 20% in the next 1-2 years and increase by upwards of 35% in Asia and South America. We spoke with an expert to find out more about this innovative position.

Green fluorescence from reef-building corals attracts symbiotic algae

(National Institutes of Natural Sciences) The researchers discovered a biological signal from corals that attracts potential symbionts.

Arizona State University team uses synthetic biology to elucidate the complexities of cell function

(Arizona State University) Arizona State University's Professor Giovanna Ghirlanda and Assistant Professor Matthias Heyden, both of the School of Molecular Sciences, and Associate Professor Sara Vaiana of the Department of Physics are viewing our cells through a new lens, enabling them to gain novel insight into the mechanisms of several cellular activities.

Emerald Textiles Deepens Management Team by Hiring New CEO, Richard Bott

Emerald Textiles (“Emerald” or the “Company”), a portfolio company of Los Angeles-based private investment firms Pacific Avenue Capital Partners, LLC (“Pacific Avenue”) and Highland Avenue Funds, LLC (“Highland”), announced that Richard (“Rich”) Bott has joined the executive management team and was appointed CEO. Mr. Bott’s appointment ...

Bayerische Patentallianz GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryBayerische Patentallianz GmbH Bayerische Patentallianz is a central patent and marketing agency that evaluates and markets the inventions, protecting, marketing and achieving financial benefits. The agency provides support and consulting services to small and medium businesses and free inventors. It also coordinates and controls the complete marketing process with the companies. Bayerische ...

Anleger sollten Gilead Sciences-Aktie übergewichten!

Foster CityLondon (www.aktiencheck.de) - Gilead Sciences-Aktienanalyse von Analyst Geoffrey Meacham von Barclays: Laut einer Aktienanalyse bleibt Geoffrey Meacham, Aktienanalyst von Barclays, bei s...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks